Читаем Нестареющее тело. Научное исследование о том, как защитить свои тело и мозг и не допустить развития неврологических заболеваний полностью

Нестареющее тело. Научное исследование о том, как защитить свои тело и мозг и не допустить развития неврологических заболеваний

Бастиан Блоэм , Майкл Окун , Рэй Дорси , Тодд Шерер

21. Bernheimer H, Birkmayer W, Hornykiewicz O, Jellinger K, Seitelberger F. Brain dopamine and the syndromes of Parkinson and Huntington. Clinical, morphological and neurochemical correlations. Journal of the Neurological Sciences. 1973;20(4):415–455.

22. Lees AJ, Tolosa E, Olanow CW. Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr. Movement Disorders. 2015;30(1):19–36.

23. Braak H, Ghebremedhin E, Rub U, Bratzke H, Del Tredici K. Stages in the development of Parkinson’s disease-related pathology. Cell and Tissue Research. 2004;318(1): 121–134; Braak H, Del Tredici K, Bratzke H, Hamm-Clement J, Sandmann-Keil D, Rub U. Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson’s disease (preclinical and clinical stages). Journal of Neurology. 2002;249(3):iii1-iii5.

24. Chaudhuri KR, Healy DG, Schapira AHV. Non-motor symptoms of Parkinson’s disease: diagnosis and management. Lancet Neurology. 2006;5(3):235–245; Park A, Stacy M. Non-motor symptoms in Parkinson’s disease.

Journal of Neurology. 2009;256(3):293–298.

25. Schrag A. Quality of life and depression in Parkinson’s disease. Journal of the Neurological Sciences. 2006;248(1):151–157; Shulman LM, Taback RL, Bean J, Weiner WJ. Comorbidity of the nonmotor symptoms of Parkinson’s disease. Movement Disorders. 2001;16(3):507–510; Martinez-Martin P, Rodriguez-Blazquez C, Kurtis MM, Chaudhuri KR. The impact of non-motor symptoms on health-related quality of life of patients with Parkinson’s disease. Movement Disorders. 2011;26(3):399–406.

26. Lees AJ, Tolosa E, Olanow CW. Four pioneers of L-dopa treatment: Arvid Carlsson, Oleh Hornykiewicz, George Cotzias, and Melvin Yahr. Movement Disorders. 2015;30(1):19–36.

27. Goetz CG. The history of Parkinson’s disease: early clinical descriptions and neurological therapies. Cold Spring Harbor Perspectives in Medicine.

2011;1(1):a008862; Birkmayer W, Hornykiewicz O. The L-3,4-dioxyphenylalanine (DOPA)-effect in Parkinson-akinesia. Wiener klinische Wochenschrift. 1961;73:787–788.

28. Cotzias GC. L-dopa for Parkinsonism. New England Journal of Medicine. 1968;278(11):630; Cotzias GC, Papavasiliou PS, Gellene R. Modification of parkinsonism – chronic treatment with L-dopa. New England Journal of Medicine. 1969;280(7):337–345; Yahr MD, Duvoisin RC, Schear MJ, Barrett RE, Hoehn MM. Treatment of parkinsonism with levodopa. Archives of Neurology. 1969;21(4):343–354.

29. Sacks O. Awakenings. Rpt. ed. Vintage; 1999./ Оливер Сакс «Пробуждения»

30. Parkinson J. An essay on the shaking palsy. Journal of Neuropsychiatry and Clinical Neurosciences. 2002;14(2):223–236.

31. Osler W, Sir. The Principles and Practice of Medicine. D. Appleton and Company; 1892.

32. Langston JW. The MPTP story. Journal of Parkinsons Disease. 2017;7(s1):S11-S19.

33. Там же.

34. Langston JW, Palfreman J. The Case of the Frozen Addicts: How the Solution of a Medical Mystery Revolutionized the Understanding of Parkinsons Disease. Rev. ed. IOS Press; 2014.

35. Langston JW. The MPTP story. Journal of Parkinsons Disease.

2017;7(s1):S11-S19; Nonnekes J, Post B, Tetrud JW, Langston JW, Bloem BR. MPTP-induced parkinsonism: an historical case series. Lancet Neurology. 2018;17(4):300–301.

36. Langston JW, Ballard P, Tetrud JW, Irwin I. Chronic parkinsonism in humans due to a product of meperidine-analog synthesis. Science. 1983;219(4587):979–980.

37. “NOVA; case of the frozen addict, the.” OpenVault from WGBH Boston/ BBC TV. February 18, 1986. http://openvault.wgbh.org/catalog/V_474C F2C8A20B4173988486AC4C605A3C. At 00:55:25.

38. Cervone C. Frozen addicts; drug addicts developed Parkinson’s disease. Las Vegas World News. December 9, 2013. www.lasvegasworldnews. com/frozen-addicts-drug-addicts-developed-parkinsons-disease/14976. Accessed December 13, 2018.

39. Desmethylprodine. Wikipedia. https://en.wikipedia.org/wiki/ Desmethylprodine. Updated December 31, 2018. Accessed March 31, 2019.

40. Hughes AJ, Daniel SE, Kilford L, Lees AJ. Accuracy of clinical diagnosis of idiopathic Parkinson’s disease: a clinico-pathological study of 100 cases. Journal of Neurology, Neurosurgery, and Psychiatry. 1992;55(3):181–184.

Перейти на страницу: